Literature DB >> 19564341

Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Yifang Chen1, Sahil Khanna, Carl S Goodyear, Yong Beom Park, Eyal Raz, Steffen Thiel, Caroline Grönwall, Jaya Vas, David L Boyle, Maripat Corr, Dwight H Kono, Gregg J Silverman.   

Abstract

Although natural Abs (NAbs) are present from birth, little is known about what drives their selection and whether they have housekeeping functions. The prototypic T15-NAb, first identified because of its protective role in infection, is representative of a special type of NAb response that specifically recognizes and forms complexes with apoptotic cells and which promotes cell-corpse engulfment by phagocytes. We now show that this T15-NAb IgM-mediated clearance process is dependent on the recruitment of C1q and mannose-binding lectin, which have known immune modulatory activities that also provide "eat me" signals for enhancing phagocytosis. Further investigation revealed that the addition of T15-NAb significantly suppressed in vitro LPS-induced TNF-alpha and IL-6 secretion by the macrophage-like cell line, RAW264.7, as well as TLR3-, TLR4-, TLR7-, and TLR9-induced maturation and secretion of a range of proinflammatory cytokines and chemokines by bone marrow-derived conventional dendritic cells. Significantly, high doses of this B-1 cell produced NAb also suppressed in vivo TLR-induced proinflammatory responses. Although infusions of apoptotic cells also suppressed such in vivo inflammatory responses and this effect was associated with the induction of high levels of IgM antiapoptotic cell Abs, apoptotic cell treatment was not effective at suppressing such TLR responses in B cell-deficient mice. Moreover, infusions of T15-NAb also efficiently inhibited both collagen-induced arthritis and anti-collagen II Ab-mediated arthritis. These studies identify and characterize a previously unknown regulatory circuit by which a NAb product of innate-like B cells aids homeostasis by control of fundamental inflammatory pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564341      PMCID: PMC2713016          DOI: 10.4049/jimmunol.0900948

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

Review 1.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

2.  Cytokine production in association with phagocytosis of apoptotic cells by immature dendritic cells.

Authors:  Munehisa Takahashi; Yoshiro Kobayashi
Journal:  Cell Immunol       Date:  2003-12       Impact factor: 4.868

3.  Mannose-binding lectin engagement with late apoptotic and necrotic cells.

Authors:  Alma J Nauta; Nicoline Raaschou-Jensen; Anja Roos; Mohamed R Daha; Hans O Madsen; Maria C Borrias-Essers; Lars P Ryder; Claus Koch; Peter Garred
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

4.  Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex.

Authors:  R William Vandivier; Carol Anne Ogden; Valerie A Fadok; Peter R Hoffmann; Kevin K Brown; Marina Botto; Mark J Walport; James H Fisher; Peter M Henson; Kelly E Greene
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

Review 5.  Dendritic cells, chemokine receptors and autoimmune inflammatory diseases.

Authors:  Petra D Cravens; Peter E Lipsky
Journal:  Immunol Cell Biol       Date:  2002-10       Impact factor: 5.126

6.  Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes.

Authors:  Kutty Selva Nandakumar; Lars Svensson; Rikard Holmdahl
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

7.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

Authors:  Christoph J Binder; Sohvi Hörkkö; Asheesh Dewan; Mi-Kyung Chang; Emily P Kieu; Carl S Goodyear; Peter X Shaw; Wulf Palinski; Joseph L Witztum; Gregg J Silverman
Journal:  Nat Med       Date:  2003-05-12       Impact factor: 53.440

Review 8.  C1q, autoimmunity and apoptosis.

Authors:  Marina Botto; Mark J Walport
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

9.  The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells.

Authors:  Peter X Shaw; Carl S Goodyear; Mi-Kyung Chang; Joseph L Witztum; Gregg J Silverman
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities.

Authors:  Ayumu Kurimoto; Tetsuhiro Ogino; Shinji Ichii; Yoshiaki Isobe; Masanori Tobe; Haruhisa Ogita; Haruo Takaku; Hironao Sajiki; Kosaku Hirota; Hajime Kawakami
Journal:  Bioorg Med Chem       Date:  2004-03-01       Impact factor: 3.641

View more
  82 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 3.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

4.  Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance.

Authors:  Daniel B Harmon; Prasad Srikakulapu; Jennifer L Kaplan; Stephanie N Oldham; Chantel McSkimming; James C Garmey; Heather M Perry; Jennifer L Kirby; Thomas A Prohaska; Ayelet Gonen; Peter Hallowell; Bruce Schirmer; Sotirios Tsimikas; Angela M Taylor; Joseph L Witztum; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-11       Impact factor: 8.311

Review 5.  Innate B Cells: the Archetype of Protective Immune Cells.

Authors:  Alexis Grasseau; Marina Boudigou; Laëtitia Le Pottier; Nedra Chriti; Divi Cornec; Jacques-Olivier Pers; Yves Renaudineau; Sophie Hillion
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

6.  IgM Plasma Cells Reside in Healthy Skin and Accumulate with Chronic Inflammation.

Authors:  R Paul Wilson; Shannon E McGettigan; Van Duc Dang; Anil Kumar; Michael P Cancro; Neda Nikbakht; William Stohl; Gudrun F Debes
Journal:  J Invest Dermatol       Date:  2019-05-30       Impact factor: 8.551

Review 7.  Extracellular DNA and autoimmune diseases.

Authors:  Hantao Lou; Matthew C Pickering
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

8.  Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration.

Authors:  Natalia Maximova; Alessandra Maestro; Davide Zanon; Annalisa Marcuzzi
Journal:  J Immunother Cancer       Date:  2020-02       Impact factor: 13.751

Review 9.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

Review 10.  Lupus nephritis: lessons from murine models.

Authors:  Anne Davidson; Cynthia Aranow
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.